Sign Up
Stories
ASRT Investors Alerted Amid Alleged Misrepresentations
Share
ASRT Investor Claims Amid Fraud Allegati...
ASRT Securities Fraud Allegations
Activist Investor Targets Alight's Impro...
ASRT Investors Alerted Amid Legal Challe...
Amplitude, Inc. Investor Lawsuit Alert
B. Riley Faces Securities Fraud Allegati...
Overview
API
Investors in Assertio Holdings, Inc. (ASRT) facing losses are urged by Hagens Berman to file claims by Mar. 5, 2024, due to recent events including a lowered price target, CEO termination, and a securities fraud class action suit. Allegations involve misrepresented product values and income reliance.
Ask a question
Could this event lead to increased regulatory scrutiny on pharmaceutical companies' financial disclosures and acquisitions?
How might the outcome of the securities fraud class action suit impact Assertio's future operations and market standing?
What measures can companies take to rebuild investor trust after allegations of misrepresentation and fraud?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage